Previous Estimates of Illicit Opioid Use in the United States Underreported
Most individuals report that their first opioid exposure involved prescription opioids for themselves or others
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
Reduction in 2024-2025 RSV-associated hospitalization rates seen among infants aged 0 to 7 months with maternal vaccination or nirsevimab
Preoperative SGLT2 Inhibitor Users Have Increased Risk for Postoperative Euglycemic Ketoacidosis
Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
Ubrogepant may treat prodromal symptoms, including photophobia, fatigue, phonophobia, cognitive dysfunction from as early as one hour
Mepolizumab Yields Lower Rate of Moderate/Severe Exacerbations in COPD
Time to first moderate or severe exacerbation longer with mepolizumab in patients with COPD, history of exacerbations, eosinophil count ≥300 cells/µL
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors
BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
Adverse events occurred more often in the BCG revaccination group, and most were due to injection-site reactions
GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity
Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women
